The FDA should expedite the development of treatments for rare diseases, considering the potential risks involved. Bulging spinal disk or large cyst? 2608
The FDA has issued Complete Response Letters blocking the approval of drugs for patients with terminal diseases, even when good safety data exists and patients in trials show meaningful benefit. …
The FDA should expedite the development of treatments for rare diseases, considering the potential risks involved. Bulging spinal disk or large cyst? 2608 Read More
